2/26
11:13 am
irwd
Ironwood Pharmaceuticals (IRWD) had its "hold" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Ironwood Pharmaceuticals (IRWD) had its "hold" rating reaffirmed by Jefferies Financial Group Inc..
2/26
09:55 am
irwd
Ironwood Pharmaceuticals (IRWD) had its price target raised by Citizens Jmp from $8.00 to $10.00. They now have a "market outperform" rating on the stock.
Low
Report
Ironwood Pharmaceuticals (IRWD) had its price target raised by Citizens Jmp from $8.00 to $10.00. They now have a "market outperform" rating on the stock.
2/25
04:27 pm
irwd
Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ... [Yahoo! Finance]
High
Report
Ironwood Pharmaceuticals Inc (IRWD) Q4 2025 Earnings Call Highlights: Strong LINZESS Sales and ... [Yahoo! Finance]
2/25
02:02 pm
irwd
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
2/25
07:05 am
irwd
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
Medium
Report
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
2/18
04:32 pm
irwd
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call [Yahoo! Finance]
Medium
Report
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call [Yahoo! Finance]
2/18
04:21 pm
irwd
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
Medium
Report
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
2/4
09:28 am
irwd
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating [Yahoo! Finance]
Low
Report
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating [Yahoo! Finance]
1/6
07:25 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Craig Hallum from a "hold" rating to a "strong-buy" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Craig Hallum from a "hold" rating to a "strong-buy" rating.
1/5
01:48 pm
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $3.00 to $5.00. They now have an "equal weight" rating on the stock.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target raised by analysts at Wells Fargo & Company from $3.00 to $5.00. They now have an "equal weight" rating on the stock.
1/5
08:33 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $8.00 price target on the stock.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $8.00 price target on the stock.
1/5
06:01 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.
1/3
05:42 am
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/2
09:39 am
irwd
Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug [Yahoo! Finance]
High
Report
Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug [Yahoo! Finance]
1/2
07:05 am
irwd
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
High
Report
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
12/16
04:38 pm
irwd
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/29
06:00 pm
irwd
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
Neutral
Report
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]
11/26
04:06 pm
irwd
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]
Medium
Report
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 [Seeking Alpha]